This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of liver and intrahepatic bile ducts
C3_LIVER_INTRAHEPATIC_BILE_DUCTS
liver neoplasm: A benign or malignant epithelial neoplasm that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of benign epithelial neoplasms include hepatocellular adenoma and intrahepatic bile duct adenoma. Representative examples of malignant epithelial neoplasms include hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1164 |
4. Check minimum number of eventsNone |
1164 |
5. Include endpointsNone |
1164 |
6. Filter based on genotype QC (FinnGen only) |
1164 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of liver and intrahepatic bile ducts
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1164 | 259 | 905 |
| Unadjusted period prevalence (%) | 0.33 | 0.09 | 0.40 |
| Median age at first event (years) | 72.52 | 72.02 | 72.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1046
- Matched controls
- 10459
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
3418.0
323.0
652
5
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
323.0
503
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
561.3
305.1
289
7
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
84.4
297.0
327
56
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
67.4
283.7
324
69
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
1585.7
261.9
244
*
130
Kela drug reimbursment
Malignant tumour
11.2
207.3
451
662
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
166.1
155
*
198
Kela drug reimbursment
Sorafenib
620.4
164.8
159
*
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
150.7
141
*
Z51.5
ICD-10 Finland
Palliative care
9.7
138.8
312
439
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
39.6
120.6
153
45
L01XE05
ATC
[U] sorafenib; oral
629.6
116.4
113
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.5
115.9
280
431
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
36.0
108.8
141
45
N02AA05
ATC
oxycodone; systemic
5.3
107.5
410
1142
JN4CD
NOMESCO Finland
Very extensive body CT
10.5
89.3
184
208
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
86.4
378
1165
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
15.3
80.0
136
101
R18
ICD-10 Finland
Ascites
20.5
78.4
119
65
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
41.4
78.3
98
26
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
343.7
64.2
64
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
17.9
61.8
98
60
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
13.4
61.4
110
91
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.3
60.2
140
190
323
Kela drug reimbursment
Sorafenib
320.1
60.0
60
*
Z94.4
ICD-10 Finland
Liver transplant status
314.2
58.9
59
*
C03DA01
ATC
spironolactone; oral
3.7
53.7
274
909
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
51.2
256
831
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
16.5
49.7
81
53
JJC00
NOMESCO Finland
Allogenic transplantation of liver
262.1
49.5
50
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
39.7
47.7
60
16
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
21.9
45.0
66
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.9
44.7
157
361
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
434.3
42.5
42
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.1
41.0
139
306
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
91.8
40.1
44
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
38.8
402
2064
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
38.8
37
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.5
38.4
120
240
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
52.1
37.9
45
9
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
52.1
37.9
45
9
127
Kela drug reimbursment
Transplant complication
15.2
37.7
63
44
JN4BD
NOMESCO Finland
Extensive body CT
3.3
37.3
215
761
A04AA02
ATC
granisetron; systemic, transdermal
5.3
35.3
114
237
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
9.4
35.1
74
84
K83.0
ICD-10 Finland
Cholangitis
10.6
35.0
69
69
K83.1
ICD-10 Finland
Obstruction of bile duct
10.8
34.8
68
67
D77
ICPC
Malignant digestive neopl other/NOS
32.7
33.7
44
14
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
10.0
33.0
67
71
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
175.4
32.9
34
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.7
32.2
96
181
103
Kela drug reimbursment
Diabetes, insulin-treated
2.3
31.6
422
2402
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
31.4
100
204
A05AA02
ATC
ursodeoxycholic acid; oral
13.5
30.4
53
41
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
18.2
30.3
47
27
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
30.3
178
631
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
20.4
30.2
45
23
L01EX02
ATC
sorafenib; oral
+∞
29.3
28
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.4
29.0
90
178
3019
Kela drug reimbursment
Lenvatinib
299.8
28.9
29
*
C03CA01
ATC
furosemide; systemic
2.1
28.0
513
3306
A10BA02
ATC
metformin; oral
2.2
27.9
416
2451
A06AD11
ATC
lactulose; oral
2.4
26.9
273
1336
1508
Kela drug reimbursment
Lenvatinib
277.7
26.8
27
*
UJK02
NOMESCO Finland
ERCP
5.7
26.8
79
147
L04AA06
ATC
mycophenolic acid; systemic
10.3
26.7
53
54
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
35.1
26.6
34
10
N02AX02
ATC
tramadol; systemic, rectal
2.0
26.5
507
3298
A07AA11
ATC
rifaximin; oral
266.8
25.8
26
*
JN4AD
NOMESCO Finland
Body CT examination
3.3
25.6
138
457
L04AD01
ATC
ciclosporin; systemic
11.9
25.6
47
41
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
25.5
342
1904
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
24.1
371
2181
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
24.0
23
*
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
245.2
23.7
24
*
K76.9
ICD-10 Finland
Liver disease, unspecified
10.6
23.2
45
44
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
16.2
22.5
36
23
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
20.0
22.2
33
17
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
15.7
21.6
35
23
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
21.3
124
430
L01EX08
ATC
lenvatinib; oral
214.0
20.6
21
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
26.1
20.5
28
11
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
18.7
20.5
31
17
B18.2
ICD-10 Finland
Chronic viral hepatitis C
21.3
20.0
29
14
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
9.1
20.0
42
48
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
36.5
19.9
25
7
JJB30
NOMESCO Finland
Excision of two segments of liver
107.0
19.6
21
*
JJ5AT
NOMESCO Finland
NA
203.6
19.6
20
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
203.6
19.6
20
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.2
18.8
73
183
H02AB02
ATC
dexamethasone; systemic
2.7
18.8
135
538
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
22.2
18.2
26
12
I81
ICD-10 Finland
Portal vein thrombosis
16.9
17.9
28
17
A04AA01
ATC
ondansetron; systemic, rectal
3.4
17.8
88
272
A98
ICPC
Health maint/preventive medicine
0.6
17.8
597
7379
JJB10
NOMESCO Finland
Atypcal resection of liver
67.8
17.8
20
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
17.8
17
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
17.8
17
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
17.3
17.4
27
16
A10AE04
ATC
insulin glargine; parenteral
2.5
17.4
146
636
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.8
17.3
119
460
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
17.3
252
1417
K92.0
ICD-10 Finland
Haematemesis
4.1
17.2
68
174
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
6.2
17.1
46
77
176
Kela drug reimbursment
Regorafenib
32.0
17.1
22
7
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
7.2
17.0
41
59
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
10.3
17.0
33
33
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
16.8
90
296
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
16.7
16
*
L01BC06
ATC
capecitabine; oral
4.2
16.1
62
155
D97
ICPC
Liver disease NOS
21.3
16.0
23
11
A10BB12
ATC
glimepiride; oral
2.3
15.9
154
722
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
60.9
15.8
18
*
JJA20
NOMESCO Finland
Open biopsy of liver
33.9
15.8
20
6
WZC30
NOMESCO Finland
Teaching
2.3
15.7
152
710
J01MA12
ATC
levofloxacin; systemic
1.9
15.5
249
1445
K72.1
ICD-10 Finland
Chronic hepatic failure
38.7
15.4
19
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
15.3
172
863
JJB71
NOMESCO Finland
Laparoscopic resection of liver
45.7
15.1
18
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
45.7
15.1
18
*
D13.4
ICD-10 Finland
Benign neoplasm: Liver
15.3
14.9
24
16
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
14.5
284
1762
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
152.0
14.5
15
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
17.3
14.3
22
13
B01AB05
ATC
enoxaparin; parenteral
1.8
14.3
325
2119
TJA10
NOMESCO Finland
Laparocentesis
43.1
14.1
17
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
13.9
174
910
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.9
13.8
38
66
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
8.1
13.6
30
38
WW500
NOMESCO Finland
Blood transfusion
3.3
13.6
70
224
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
13.6
13
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
50.6
12.9
15
*
TK800
NOMESCO Finland
Hemodialysis
4.4
12.7
46
109
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.0
12.7
40
82
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
12.7
52
1242
XX4BW
NOMESCO Finland
NA
32.4
12.6
16
5
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
12.5
12
*
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
12.5
12
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
131.5
12.5
13
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.4
12.3
36
68
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.7
12.3
23
22
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
38.0
12.2
15
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
11.2
12.1
22
20
T90
ICPC
Diabetes non-insulin dependent
1.7
12.0
276
1788
205
Kela drug reimbursment
Chronic hypertension
1.6
11.8
405
2931
A10BH01
ATC
sitagliptin; oral
2.1
11.5
136
694
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
11.5
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.5
471
3562
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
11.4
188
2889
C10AA05
ATC
atorvastatin; oral
0.6
11.1
227
3315
L01XE21
ATC
[U] regorafenib; oral
28.3
10.7
14
5
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.8
10.6
186
1099
B01AB10
ATC
tinzaparin; parenteral
2.5
10.6
84
353
WX402
NOMESCO Finland
General anaesthesia
2.0
10.5
136
717
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
10.4
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
10.3
256
1687
K70.0
ICD-10 Finland
Alcoholic fatty liver
9.7
10.3
20
21
UJK12
NOMESCO Finland
Peroral cholangioscopy
19.0
10.3
15
8
SPAT1262
SPAT
Handing over of treatment supplies
1.7
10.2
216
1356
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
10.2
58
200
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
10.0
119
609
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
10.0
297
2051
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
16.9
9.9
15
9
R4110
NOMESCO Finland
Physiotherapy
1.6
9.8
264
1776
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
4.2
9.7
36
89
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
55.5
9.7
11
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
11.5
9.6
17
15
XQ902
NOMESCO Finland
Other photography
10.1
9.5
18
18
C07AA05
ATC
propranolol; systemic
1.9
9.5
138
762
L01XE29
ATC
[U] lenvatinib; oral
100.9
9.4
10
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
17.7
9.4
14
8
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
9.4
136
751
A06AH03
ATC
naloxegol; oral
5.6
9.4
26
47
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
9.4
47
1045
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
12.5
9.4
16
13
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
8.1
9.4
20
25
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
9.3
178
1079
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
9.2
202
1278
A02BC02
ATC
pantoprazole; systemic
1.5
9.1
605
5002
SPAT1109
SPAT
Analgesia with portable analgesic pump
9.1
9.0
18
20
JAH00
NOMESCO Finland
Laparotomy
3.3
8.9
44
139
UJF32
NOMESCO Finland
Coloscopy
1.6
8.9
266
1833
ZXC40
NOMESCO Finland
Use of ultrasound
10.8
8.8
16
15
A79
ICPC
Malignancy NOS
5.4
8.8
25
47
JJA43
NOMESCO Finland
Destruction of lesion of liver
50.4
8.7
10
*
L04AA10
ATC
sirolimus; oral
50.4
8.7
10
*
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
50.4
8.7
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
8.7
44
142
SPAT1053
SPAT
Memory test
0.5
8.6
77
1411
A10AE05
ATC
insulin detemir; parenteral
2.4
8.6
74
326
K70.1
ICD-10 Finland
Alcoholic hepatitis
8.3
8.6
18
22
K92.1
ICD-10 Finland
Melaena
2.2
8.6
86
406
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.5
136
2128
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.6
8.5
37
106
JKA20
NOMESCO Finland
Cholecystectomy
2.8
8.5
53
195
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
12.9
8.4
14
11
L01EX05
ATC
regorafenib; oral
+∞
8.3
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.9
8.3
49
176
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
8.2
125
703
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
14.6
8.2
13
9
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
14.6
8.2
13
9
369
Kela drug reimbursment
Regorafenib
14.6
8.2
13
9
A10BB01
ATC
glibenclamide; oral
2.1
8.2
97
495
SPAT1255
SPAT
Intravenous administration of medicine
2.2
8.1
77
357
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.2
8.1
41
132
C24.00
ICD-10 Finland
Hepatic duct
33.6
8.1
10
*
JJB20
NOMESCO Finland
Excision of single segment of liver
33.6
8.1
10
*
K76.89
ICD-10 Finland
Other specified diseases of liver
33.6
8.1
10
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.6
8.1
56
221
ZX120
NOMESCO Finland
Intravenous
2.0
8.0
106
563
B01AF01
ATC
rivaroxaban; oral
0.4
7.9
32
775
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.6
7.9
19
29
B01AF02
ATC
apixaban; oral
0.4
7.9
30
744
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
7.8
130
752
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
45.3
7.7
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.9
7.7
30
79
K76.7
ICD-10 Finland
Hepatorenal syndrome
25.2
7.6
10
*
A41.8
ICD-10 Finland
Other specified sepsis
3.6
7.4
32
92
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
80.6
7.4
8
*
N06DX01
ATC
memantine; oral
0.4
7.4
24
636
N02AA01
ATC
morphine; systemic, rectal
3.4
7.4
33
98
6603
FHL
Delete a block
+∞
7.3
7
*
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
7.3
7
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
9.4
7.3
14
15
A10BG03
ATC
pioglitazone; oral
3.0
7.2
39
133
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
30.2
7.2
9
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
20.2
7.1
10
5
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
6.6
7.1
17
26
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
8.0
7.1
15
19
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
8.8
7.1
14
16
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
10.1
7.0
13
13
L04AX01
ATC
azathioprine; systemic
2.7
7.0
45
169
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.0
7.0
21
43
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.5
7.0
73
1282
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
13.9
6.9
11
8
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
6.8
54
1030
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
6.8
143
891
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.8
402
3182
R83
ICPC
Respiratory infection other
0.4
6.8
29
681
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.8
6.7
40
146
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
7.9
6.6
14
18
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
6.6
91
492
XKD00
NOMESCO Finland
Uroflowmetry
0.6
6.5
119
1815
RS220
NOMESCO Finland
NA
4.3
6.4
22
52
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
70.2
6.4
7
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
14.4
6.4
10
7
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
14.4
6.4
10
7
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
6.4
62
292
N02BE01
ATC
paracetamol; systemic, rectal
0.7
6.4
621
7027
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.4
6.3
19
518
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.4
6.3
51
221
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.3
159
1042
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
6.3
6
*
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
6.3
6
*
1551A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts
+∞
6.3
6
*
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
6.2
97
551
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
12.6
6.1
10
8
K51.8
ICD-10 Finland
Other ulcerative colitis
5.2
6.0
17
33
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
6.0
23
568
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
370
358
14.69
307.65
4.4
3.5
1022.0
12013.9
u/ml
0.78
332
298
543
1035
8.96
304.08
4.4
4.1
30.2
24.9
ug/l
0.14
481
888
259
228
14.32
259.03
4.9
2.3
43.0
32.6
umol/l
4.68
220
184
420
879
6.91
206.09
5.9
2.2
0.2
0.2
g/l
9.99
396
808
210
207
12.16
193.34
3.7
3.4
533.8
341.3
u/ml
0.41
198
192
151
98
17.56
177.49
1.3
1.1
1.7
1.6
g/l
1.22
143
89
395
1012
5.39
150.62
12.2
2.8
23.7
10.4
umol/l
5.56
371
894
323
980
4.18
94.88
13.2
6.9
8.8
11.4
mmol/l
8.77
308
930
66
35
19.93
84.56
2.3
2.1
787.4
825.4
e6/l
0.03
51
28
59
31
20.00
75.81
2.2
1.7
1050.4
52362.7
e6/l
0.51
40
21
239
726
3.88
68.28
2.6
1.7
1.6
1.7
%
0.52
215
593
66
56
12.43
65.71
1.6
1.2
—
—
—
0
0
53
38
14.57
58.19
34.5
26.8
133.5
128.8
ug/l
0.13
43
33
503
2568
2.69
57.44
13.3
3.1
76.2
35.5
u/l
5.66
489
2447
454
2267
2.64
53.39
16.3
4.2
74.6
81.8
%
7.51
438
2215
673
4064
2.56
52.79
16.1
5.0
30.8
34.3
g/l
39.67
638
3751
58
63
9.64
48.67
1.3
1.1
84.6
197.3
titre
0.47
13
11
509
2784
2.47
48.25
5.5
2.5
54.7
57.5
u/l
0.76
484
2568
719
4630
2.45
46.76
26.5
6.3
29.1
12.8
umol/l
12.88
695
4379
40
28
14.76
44.37
1.7
1.1
10.2
13.9
g/l
1.20
29
18
106
245
4.66
42.92
9.1
3.8
1.8
1.8
mg/l
0.00
96
216
329
1549
2.57
42.05
6.5
3.3
0.8
0.8
mmol/l
9.00
314
1441
73
124
6.21
41.60
1.4
1.5
114.0
140.9
u/ml
—
6
23
209
802
2.96
39.58
5.1
2.4
30.0
33.5
u/l
0.90
192
673
82
168
5.18
38.24
1.3
1.3
—
—
—
0
0
72
134
5.66
37.31
1.4
1.2
—
—
—
0
0
69
124
5.85
37.10
1.4
1.3
388.4
260.1
u/ml
1.93
53
69
83
183
4.81
35.51
10.6
5.1
1044.4
354.9
iu/ml
0.98
32
28
168
604
3.08
35.50
2.1
2.6
13.0
10.9
g/l
3.77
149
546
283
1390
2.37
31.90
2.7
2.7
25.5
22.2
%
2.36
261
1183
34
32
10.91
31.44
1.1
1.0
—
—
—
0
0
286
1462
2.27
29.05
2.6
2.6
2.2
2.2
g/l
0.08
266
1342
35
47
7.65
24.71
1.0
1.0
287.7
284.5
mg/l
0.06
28
42
244
1243
2.22
24.57
3.6
3.9
249.8
244.8
u/l
0.25
237
1174
290
1594
2.09
23.97
2.7
2.6
13.0
12.1
umol/l
1.06
277
1470
238
4062
0.48
22.47
3.3
4.7
22.2
21.8
%
0.14
95
2134
36
61
6.06
20.51
1.0
1.0
—
—
—
0
0
618
7782
0.56
20.23
5.1
5.0
6.6
6.2
mmol/l
8.74
525
6901
605
7652
0.56
19.95
5.4
4.7
4.2
4.3
mmol/l
2.28
524
6918
631
7866
0.57
19.33
5.5
5.3
2.4
2.5
mmol/l
1.45
538
7051
345
5039
0.55
18.51
3.7
5.4
2.2
4.4
ug/l
1.77
267
4439
602
7557
0.58
18.26
5.3
4.7
1.2
1.4
mmol/l
11.25
516
6760
153
2878
0.46
17.97
2.2
3.3
0.8
0.8
ug/l
0.59
93
2049
635
4785
1.72
17.94
12.5
3.2
228.3
56.4
u/l
39.64
598
4371
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
105
426
2.61
17.36
3.1
2.7
0.3
0.3
u/ml
1.05
60
242
345
2208
1.80
17.28
4.5
2.5
—
—
—
0
0
67
215
3.25
16.95
3.4
2.4
212.7
204.1
%
0.30
67
205
40
89
4.62
16.91
1.6
1.3
—
—
—
0
0
115
500
2.44
16.44
5.9
4.5
22.8
24.0
mmol/l
2.84
109
455
233
3718
0.53
16.22
2.5
2.3
—
—
—
0
0
236
1377
1.90
15.74
9.4
5.8
1.1
1.0
mmol/l
0.67
218
1264
22
29
7.71
15.73
1.5
1.2
—
—
—
0
0
614
7546
0.61
15.41
9.2
6.6
44.2
41.3
mmol/mol
7.09
536
6842
603
7432
0.61
15.16
39.1
17.2
74.3
72.2
ml/min/173m2
1.36
545
6222
100
2075
0.43
14.76
2.0
1.6
1.7
1.3
mmol/l
3.19
89
1694
183
1005
1.97
14.53
5.6
4.0
1.3
2.0
mmol/l
1.77
128
783
594
7310
0.62
14.37
5.0
4.2
1.4
1.3
mmol/l
4.40
511
6488
79
307
2.69
14.22
2.1
1.7
—
—
—
0
0
16
16
10.13
14.04
1.7
1.4
—
—
—
0
0
182
1010
1.95
13.99
5.5
4.0
5.6
5.8
kpa
2.76
175
974
574
7090
0.62
13.75
4.4
4.3
2.7
2.1
mu/l
3.82
494
6270
533
4017
1.60
13.64
7.8
4.4
—
—
—
0
0
16
18
9.00
12.91
1.1
1.1
—
—
—
0
0
606
4756
1.57
12.72
19.5
8.8
4.4
4.4
e9/l
0.13
553
4105
759
8710
0.63
11.89
55.5
26.6
122.1
133.6
g/l
57.43
725
8521
759
8708
0.63
11.85
55.0
26.4
4.1
4.4
e12/l
39.52
720
8391
759
8705
0.63
11.78
55.0
26.4
206.6
232.7
e9/l
12.41
723
8423
45
143
3.23
11.61
6.2
6.5
11.4
12.3
mg/l
0.50
40
132
436
5604
0.65
11.39
4.1
3.5
14.8
15.1
pmol/l
1.82
379
4936
136
741
1.95
10.94
1.8
1.7
—
—
—
0
0
100
495
2.12
10.48
2.0
1.9
1.2
2.2
ug/l
0.71
93
427
25
57
4.46
10.29
1.2
1.3
—
—
—
0
0
170
1052
1.72
9.00
4.8
3.8
—
—
—
0
0
741
8395
0.68
8.85
32.4
11.1
45.2
25.7
u/l
33.60
715
8023
571
4654
1.45
8.63
10.4
7.3
1.2
1.2
mmol/l
1.81
479
3891
754
8497
0.68
8.54
44.6
22.0
4.0
4.0
mmol/l
0.99
722
8247
754
8481
0.68
8.26
44.4
21.8
137.6
139.6
mmol/l
46.07
725
8242
259
1824
1.54
8.07
7.9
3.2
2.5
2.5
mmol/l
7.49
242
1589
525
4262
1.42
7.86
9.5
6.5
1.2
1.2
mmol/l
3.41
503
3833
119
692
1.80
7.80
4.4
3.2
59.9
59.1
ml/min/173m2
0.06
57
295
159
2402
0.61
7.76
1.6
1.6
16.5
19.7
nmol/l
2.67
142
2027
640
5408
1.41
7.48
11.4
5.2
7.4
6.9
mmol/l
4.99
614
5101
147
921
1.68
7.40
7.5
7.4
1.9
1.4
mmol/l
2.67
136
877
221
1571
1.50
6.48
21.2
29.6
1.6
1.5
inr
0.50
24
211
8
336
0.23
6.29
1.6
1.8
—
—
—
0
0
19
53
3.63
6.05
1.6
1.5
7.0
6.8
u/l
0.01
12
25
38
159
2.44
6.00
3.4
3.1
56.1
60.3
%
0.84
38
159
182
1262
1.52
5.98
8.3
7.3
0.3
1.1
mmol/l
2.14
138
969
24
79
3.08
5.94
1.0
1.2
41.6
54.7
u/l
1.15
18
54
181
1258
1.52
5.88
8.3
7.3
4.9
5.1
kpa
1.91
169
1188
181
1258
1.52
5.88
8.3
7.2
12.2
11.6
kpa
0.93
169
1189
15
36
4.21
5.83
2.7
2.5
66.5
60.5
u/ml
0.05
15
36
107
659
1.69
5.75
9.4
9.5
94.1
93.8
%
0.19
107
654
129
835
1.61
5.72
5.1
3.3
4.9
4.5
kpa
1.25
123
803
39
174
2.28
5.37
3.3
3.6
2.9
1.7
%
0.64
27
139
103
645
1.65
5.21
1.8
1.4
—
—
—
0
0
372
3023
1.34
4.92
7.6
3.4
2.3
2.3
mmol/l
1.04
345
2596
119
784
1.58
4.91
6.1
3.9
1.2
1.2
mmol/l
1.36
110
679
148
1025
1.51
4.88
9.2
7.9
116.6
120.4
g/l
1.45
141
986
34
153
2.26
4.63
3.2
2.8
4.3
4.8
e9/l
0.43
34
153
735
6612
1.30
4.46
28.3
7.6
181.7
81.3
u/l
48.99
705
6171
62
1041
0.57
4.46
1.1
1.3
69.6
38.4
iu/ml
0.24
19
318
29
126
2.33
4.29
1.1
1.3
—
—
—
0
0
61
995
0.59
3.94
1.1
1.2
21.8
16.4
u/ml
0.16
23
350
34
167
2.07
3.78
2.7
2.1
2.1
1.7
mmol/l
1.16
34
162
7
8
8.79
3.77
1.0
1.0
—
—
—
0
0
326
2689
1.29
3.71
4.2
3.6
1.0
0.5
e6/l
1.44
281
2108
335
3984
0.78
3.69
1.9
2.1
87.9
92.1
pmol/l
0.85
163
2154
45
247
1.85
3.66
1.2
1.5
267.4
252.7
ug/g
0.16
22
150
538
6042
0.80
3.62
5.2
4.1
23.7
14.6
mm/h
15.60
477
5493
102
697
1.51
3.61
8.1
6.5
23.1
24.5
mmol/l
3.02
94
652
204
1589
1.34
3.48
3.5
3.4
1.3
1.3
e6/l
0.00
148
940
46
259
1.81
3.47
2.1
2.5
124.6
84.3
ug/min
0.29
28
156
97
664
1.50
3.42
10.0
9.3
0.7
0.7
%
0.15
97
659
85
571
1.53
3.28
9.9
9.7
23.6
24.4
mmol/l
1.33
80
528
48
791
0.59
3.25
2.5
2.2
10.5
12.3
nmol/l
0.70
35
677
21
91
2.33
3.18
2.0
2.4
889.6
663.8
ml
1.06
11
54
579
6391
0.81
3.08
51.2
22.0
15.3
14.0
%
49.05
564
6225
750
8041
0.81
2.90
39.6
18.4
37.0
29.2
mg/l
7.13
717
6656
133
1000
1.37
2.85
2.8
3.1
230.0
269.1
ng/l
0.60
122
913
0
72
0.00
2.79
0.0
1.0
—
43.2
—
0
38
0
72
0.00
2.79
0.0
1.0
—
576.0
—
0
39
256
2126
1.26
2.68
3.6
2.8
5.5
3.8
e6/l
2.13
242
1882
15
62
2.44
2.54
1.4
1.2
—
—
—
0
0
38
224
1.72
2.53
3.4
2.7
15.3
15.7
%
0.14
12
120
41
247
1.68
2.52
1.4
1.4
—
—
—
0
0
41
247
1.68
2.52
1.4
1.4
—
—
—
0
0
354
4046
0.82
2.49
4.5
3.9
0.0
0.0
estimate
0.50
69
757
120
909
1.36
2.48
1.8
2.8
65.3
65.9
g/l
0.26
103
818
78
1087
0.70
2.47
3.6
4.8
33.8
32.4
%
0.49
51
708
92
669
1.41
2.43
10.1
9.2
1.4
1.4
%
0.15
92
664
68
468
1.48
2.40
6.9
4.8
1.7
1.6
%
0.71
61
436
349
3981
0.82
2.38
6.0
5.2
0.0
0.0
estimate
0.00
73
788
352
4011
0.82
2.38
4.5
3.9
0.0
0.0
estimate
0.00
74
785
12
48
2.52
2.19
1.7
3.8
71.6
113.4
nmol/l
1.11
12
48
395
3502
1.19
2.14
4.3
3.6
—
—
—
0
0
44
285
1.57
2.08
1.7
1.6
—
164.6
—
0
13
642
6889
0.85
2.07
40.2
19.7
35.0
38.8
%
14.11
399
4227
96
724
1.36
2.07
2.9
2.1
401.4
372.4
nmol/l
0.62
89
645
28
161
1.76
2.07
1.7
1.4
32713.5
99271.9
e6/l
0.90
20
101
299
2593
1.21
2.05
2.7
2.2
3.7
3.1
mg/l
3.26
254
2199
6
15
4.02
2.04
1.2
1.9
—
—
—
0
0
30
177
1.71
2.04
1.8
1.7
—
—
—
0
0
21
111
1.91
2.01
3.7
3.7
60.2
56.4
%
—
10
77
13
57
2.30
1.98
1.8
2.2
—
—
—
0
0
0
52
0.00
1.88
0.0
1.4
—
—
—
0
0
196
1654
1.22
1.77
3.4
3.1
0.8
1.0
e6/l
0.76
140
1001
56
398
1.43
1.74
4.5
3.8
2.2
1.5
mmol/l
1.21
56
392
29
178
1.65
1.74
1.8
1.5
827.3
1542.6
e6/l
2.03
24
129
281
3186
0.84
1.70
2.9
2.2
73.7
77.7
nmol/l
1.40
249
2753
37
244
1.53
1.67
2.1
1.6
—
—
—
0
0
36
236
1.54
1.66
2.2
1.7
—
—
—
0
0
5
14
3.58
1.61
1.8
2.9
2321.4
5875.1
u/l
—
5
14
6
20
3.01
1.58
1.3
1.5
—
—
—
0
0
50
688
0.71
1.54
1.7
1.6
—
—
—
0
0
12
232
0.51
1.53
1.3
1.3
—
—
—
0
0
319
2852
1.16
1.50
3.5
3.2
7.2
7.6
mmol/l
1.20
251
2344
334
2997
1.16
1.50
4.3
4.0
12.5
9.0
mg/mmol
0.79
232
1994
23
142
1.63
1.39
1.9
1.6
—
—
—
0
0
48
349
1.39
1.37
1.3
1.3
—
—
—
0
0
271
2413
1.16
1.34
4.3
3.0
6063.4
7789.0
umol/l
0.20
239
2020
15
84
1.80
1.27
1.3
1.1
—
224.3
miu/ml
—
0
25
39
278
1.42
1.26
4.4
3.1
8.4
7.8
kpa
1.29
34
251
156
1335
1.19
1.25
2.9
2.5
2.1
1.8
%
2.01
140
1181
6
25
2.41
1.24
1.3
1.3
—
—
—
0
0
11
202
0.54
1.23
1.3
1.3
—
—
—
0
0
13
225
0.57
1.19
1.3
1.6
0.0
25.0
iu/ml
—
5
54
15
86
1.75
1.19
1.9
1.6
—
—
—
0
0
31
214
1.46
1.19
1.5
1.6
—
—
—
0
0
192
1684
1.17
1.16
2.1
1.7
3.4
1.6
mg/l
2.63
158
1328
254
2824
0.87
1.16
2.1
2.2
213.4
252.6
u/l
0.40
237
2627
10
50
2.01
1.16
3.3
2.0
—
—
—
0
0
17
272
0.62
1.16
1.1
1.0
—
—
—
0
0
12
65
1.85
1.13
1.3
1.4
—
—
—
0
0
19
119
1.61
1.12
2.1
1.6
—
—
—
0
0
27
387
0.69
1.11
1.6
1.4
—
—
—
0
0
57
725
0.78
1.09
1.2
1.3
—
—
—
0
0
14
81
1.74
1.09
2.4
1.6
—
—
—
0
0
8
41
1.96
1.09
1.8
1.2
—
—
—
0
0
7
32
2.19
1.08
1.6
1.4
—
—
—
0
0
15
89
1.69
1.08
1.3
1.2
1.2
5.1
u/ml
—
5
29
17
264
0.64
1.04
1.2
1.3
—
—
—
0
0
143
1240
1.17
1.01
2.1
1.9
—
—
—
0
0
11
189
0.58
1.01
1.4
1.3
413.8
535.9
mg/l
1.13
11
176
9
159
0.56
0.98
2.1
1.6
—
—
—
0
0
11
61
1.81
0.98
3.2
3.0
—
—
—
0
0
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
362
3357
1.11
0.95
3.5
2.8
245.8
173.5
ug/l
2.48
327
3021
602
5734
1.10
0.93
4.8
4.9
1333.6
2039.7
e6/l
0.23
12
113
22
150
1.48
0.93
1.4
1.4
9.4
7.4
u/l
0.43
12
116
214
1929
1.13
0.91
3.8
4.2
390.0
328.8
ng/l
0.14
186
1683
27
193
1.41
0.91
1.4
1.5
—
—
—
0
0
17
111
1.54
0.88
1.5
1.6
—
—
—
0
0
10
168
0.59
0.87
1.1
1.2
—
3.2
—
0
21
6
30
2.01
0.87
1.0
1.2
7.4
6.9
mmol/l
—
6
30
34
256
1.34
0.85
1.6
1.4
—
—
—
0
0
303
3272
0.90
0.85
2.8
3.3
1417.3
2113.2
ng/l
1.42
263
2865
15
96
1.57
0.84
1.4
1.9
—
—
—
0
0
10
166
0.60
0.83
1.1
1.2
—
3.3
—
0
14
20
138
1.46
0.82
1.4
1.4
—
—
—
0
0
69
573
1.22
0.81
3.6
3.0
0.7
0.4
e6/l
0.48
69
556
141
1247
1.15
0.80
2.1
1.8
—
—
—
0
0
0
26
0.00
0.78
0.0
2.6
—
13.2
—
0
26
7
123
0.57
0.78
1.0
1.2
—
46.6
—
0
6
197
1788
1.12
0.76
2.1
1.9
—
—
—
0
0
14
91
1.55
0.75
1.4
1.2
2.1
6.5
u/ml
—
8
43
13
83
1.57
0.75
1.2
1.4
—
—
—
0
0
14
206
0.68
0.71
1.3
1.7
—
—
—
0
0
15
101
1.49
0.70
1.5
1.8
—
—
—
0
0
7
41
1.71
0.70
1.3
1.9
—
—
—
0
0
7
41
1.71
0.70
1.3
1.9
—
—
—
0
0
10
61
1.64
0.68
1.8
1.4
10.9
15.7
umol/l
—
10
56
16
110
1.46
0.68
1.5
1.6
—
—
—
0
0
7
42
1.67
0.68
1.3
1.9
—
—
—
0
0
9
59
1.53
0.68
1.1
1.1
—
—
—
0
0
5
28
1.79
0.66
1.4
1.2
—
—
—
0
0
16
111
1.45
0.66
1.5
1.6
—
—
—
0
0
16
111
1.45
0.66
1.5
1.6
—
—
—
0
0
11
70
1.58
0.65
1.2
1.3
—
—
—
0
0
80
691
1.17
0.65
3.5
4.2
91.2
103.5
ng/l
0.76
71
595
10
154
0.65
0.64
1.1
1.1
—
—
—
0
0
16
112
1.43
0.63
1.5
1.6
—
—
—
0
0
11
71
1.55
0.62
1.4
1.4
—
—
—
0
0
11
71
1.55
0.62
1.4
1.4
—
—
—
0
0
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
98
1100
0.88
0.57
14.4
8.9
—
—
—
0
0
210
2257
0.92
0.55
4.9
4.2
0.0
0.0
estimate
0.50
60
733
12
82
1.47
0.54
1.2
1.2
—
—
—
0
0
12
83
1.45
0.52
1.2
1.7
—
—
—
0
0
12
83
1.45
0.52
1.2
1.7
—
—
—
0
0
12
83
1.45
0.52
1.2
1.7
—
—
—
0
0
227
2123
1.09
0.51
1.8
1.8
1205.3
1165.1
nmol/l
0.25
175
1593
15
109
1.38
0.51
1.5
1.6
—
—
—
0
0
38
316
1.21
0.50
1.8
2.7
0.1
0.0
g/l
0.34
28
287
36
298
1.21
0.49
1.8
2.7
0.0
0.0
g/l
0.00
26
270
165
1776
0.92
0.46
5.3
4.3
1.0
1.0
kg/l
1.57
36
284
17
130
1.31
0.44
1.9
1.5
—
—
—
0
0
10
140
0.71
0.43
1.1
1.2
—
1.9
—
0
7
5
31
1.62
0.43
1.6
2.5
262.6
216.8
u/l
—
5
31
62
547
1.14
0.43
1.6
1.9
1.3
1.5
g/l
1.61
51
471
8
56
1.43
0.42
1.9
1.6
—
—
—
0
0
8
56
1.43
0.42
1.9
1.6
—
—
—
0
0
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.8
—
2.3
—
0
7
15
194
0.77
0.40
1.4
1.5
—
—
—
0
0
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
0.9
—
0
14
296
3092
0.94
0.37
4.8
4.2
—
—
—
0
0
11
145
0.76
0.34
1.0
1.1
—
—
—
0
0
6
44
1.37
0.34
1.2
1.3
—
—
—
0
0
11
82
1.34
0.34
1.3
1.1
—
—
—
0
0
18
145
1.25
0.34
1.1
1.1
—
—
—
0
0
34
293
1.17
0.34
1.8
2.8
0.0
0.0
g/l
0.00
25
269
36
312
1.16
0.33
3.4
3.2
22.9
24.9
mmol/l
1.84
30
265
39
443
0.88
0.31
4.7
4.4
23.8
24.8
mmol/l
1.22
34
409
7
52
1.35
0.31
2.0
2.2
0.1
0.2
e9/l
—
7
45
128
1364
0.93
0.31
1.2
1.2
1.7
1.7
u/ml
0.01
18
335
7
54
1.30
0.30
2.0
2.1
300.3
587.4
e6/l
—
7
45
39
344
1.14
0.30
4.2
3.4
3.9
4.3
pmol/l
1.30
31
299
7
56
1.25
0.29
1.6
1.4
—
—
—
0
0
7
56
1.25
0.29
1.6
1.4
—
—
—
0
0
8
110
0.73
0.29
1.1
1.1
—
44.6
—
0
19
15
121
1.24
0.28
2.1
2.8
—
—
—
0
0
36
317
1.14
0.28
1.2
1.8
43.8
36.9
u/l
0.79
27
276
11
85
1.30
0.28
1.4
1.2
2.1
0.6
nmol/l
0.50
11
79
44
394
1.12
0.27
1.7
2.7
13.3
10.8
g/l
1.28
33
335
20
168
1.19
0.27
2.4
1.4
—
—
—
0
0
105
984
1.07
0.26
2.3
2.7
6.1
6.6
ug/l
0.10
87
859
47
424
1.11
0.26
1.9
2.6
7.3
7.3
g/l
0.04
30
316
8
67
1.20
0.26
1.9
1.5
—
—
—
0
0
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
37
332
1.12
0.23
1.8
2.6
35.5
36.6
g/l
0.46
28
285
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
5.8
—
—
—
0
0
0
10
0.00
0.21
0.0
3.1
—
78.5
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
6.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
43
395
1.09
0.19
2.0
2.7
3.0
3.1
g/l
0.64
30
310
46
424
1.09
0.19
2.0
2.6
—
—
—
0
0
46
424
1.09
0.19
2.0
2.6
4.1
3.9
g/l
0.58
30
304
9
79
1.14
0.15
1.3
1.1
2.6
1.5
nmol/l
—
9
65
39
362
1.08
0.14
1.8
2.8
0.8
1.7
g/l
0.66
29
313
17
150
1.14
0.14
2.4
1.5
—
—
—
0
0
25
270
0.92
0.10
1.3
1.2
—
—
—
0
0
21
193
1.09
0.10
1.2
1.2
—
—
—
0
0
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
32
301
1.06
0.09
1.6
1.5
—
—
—
0
0
7
67
1.05
0.08
1.9
1.4
—
—
—
0
0
7
67
1.05
0.08
1.9
1.4
—
—
—
0
0
10
112
0.89
0.07
3.7
3.6
—
—
—
0
0
47
452
1.04
0.07
1.5
1.9
—
—
—
0
0
209
2120
0.98
0.07
1.8
1.8
442.2
14368906.0
pmol/l
1.26
162
1726
42
403
1.04
0.07
1.4
1.8
—
—
—
0
0
71
690
1.03
0.06
4.2
4.0
1.1
1.9
mmol/l
1.06
49
508
387
3839
1.01
0.06
4.3
4.4
39.9
53.9
ng/l
1.40
315
3040
22
232
0.95
0.05
2.8
2.3
118.5
128.1
g/l
1.05
15
172
75
736
1.02
0.04
4.1
3.9
4.8
5.2
kpa
3.28
65
675
23
220
1.05
0.03
1.2
1.2
—
—
—
0
0
43
419
1.03
0.03
2.0
2.8
—
—
—
0
0
11
102
1.08
0.03
1.5
1.5
17.7
13.8
u/l
1.02
11
94
23
221
1.04
0.03
1.2
1.2
—
—
—
0
0
14
147
0.95
0.01
1.4
1.1
—
—
—
0
0
31
316
0.98
0.00
1.1
1.2
12.0
155.6
iu/ml
—
7
116
10
98
1.02
0.00
1.7
1.6
—
—
—
0
0
14
142
0.99
0.00
2.3
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
7
70
1.00
0.00
1.0
1.3
—
68.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
38
380
1.00
0.00
2.1
3.5
36.8
93.3
mg/l
0.98
25
318
0
6
0.00
0.00
0.0
1.0
—
25.9
—
0
6
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
6
67
0.89
0.00
1.0
1.3
—
55.0
—
0
8
5
58
0.86
0.00
5.2
3.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
38
380
1.00
0.00
2.1
3.5
56.0
73.8
mg/l
0.44
25
314
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS – Malignant neoplasm of liver and intrahepatic bile ducts
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).